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Abstract
Tuberculosis (TB) is one of the most important cause of morbidity and death among infec-
tious diseases, and continuous efforts are needed to improve diagnostic tools and therapy.
Previous published studies showed that the absolute cells number of monocytes or lympho-
cytes in peripheral blood or yet the ratio of monocytes to lymphocytes displayed the ability to
predict the risk of active TB. In the present study we evaluated the ratio of monocytes to lym-
phocytes variation and we also analyzed the ex-vivo expression of CD64 on monocytes as
tools to identify biomarkers for discriminating TB stages. Significant differences were found
when the average ratio of monocytes to lymphocytes of active TB patients was compared
with latent TB infection (LTBI) subjects, cured TB and healthy donors (HD). By the receiver
operator characteristics (ROC) curve analysis the cut-off value of 0.285, allowed the dis-
crimination of active TB from HD, with a sensitivity of 91.04% and a specificity of 93.55%
(95% of confidence interval: 0.92–0.99). The ROC curve analysis comparing TB patients
and LTBI groups, led to a sensitivity and the specificity of the assay of 85.07% and 85.71%,
respectively (95% of confidence interval: 0.85 to 0.96). The upregulation of CD64 expres-
sion on circulating monocytes in active TB patients could represent an additional biomarker
for diagnosis of active TB. In conclusion, we found that the ML ratio or monocyte absolute
count or phenotypic measures show predictive value for active TB.
Introduction
Tuberculosis (TB) is one of the most important cause of morbidity and death among the all
infectious diseases [1]. New diagnostic tools and therapies are needed. Diagnosis of active TB
disease still represents a challenge for the clinical management due to the difficulty related to
the detection of Mycobacterium tuberculosis (Mtb) in sputum [2]. Moreover, the efficacy of
therapy which is evaluated by sputum culture conversion, needs several weeks to get results.
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Interferon-γ Release Assays (IGRAs) are attractive tests for latent TB infection (LTBI) diagno-
sis. However they have limitations as they cannot distinguish between subjects with LTBI and
active TB disease, and are inadequate for monitoring treatment response[3–5]; moreover they
also poorly predict those infected individuals who will progress to active TB[2,6–13]. There-
fore, it would be very useful to have a simple and rapid method to screen patients with active
TB among the LTBI subjects and to evaluate the anti-microbial therapy success.
The absolute number of monocytes or lymphocytes in peripheral blood or yet the ratio of
monocytes to lymphocytes (ML ratio) predict the risk of active TB development in HIV-
infected patients co-infected with Mtb or in children born from HIV-infected mothers[14–
17]. Moreover, recent data also have highlighted that the increase of the ML ratio is associated
with changes of gene transcription in monocytes that may influence their functional anti-
mycobacterial profiles. [18–20] It has been described that human CD14+monocyte are com-
posed by two subsets based on CD16 expression and relative percentages of CD16+ monocytes
increase along with TB disease severity [18]. However, whether this unbalance is beneficial or
detrimental to host defense remains to be elucidated. Moreover, human monocytes are prone
to differentiate towards an anti-inflammatory (M2-like) macrophage activation program dur-
ing Mtb infection[19].
In this paper we have investigated on the ML ratio in subjects with LTBI and in patients
with active TB before and after anti-mycobacterial therapy, to correlate this value with the dif-
ferent conditions of infection/disease. The expression of different surface molecules in circu-
lating monocytes was also evaluated.
Materials and methods
Characteristics of the enrolled individuals
A total of 173 individuals were prospectively enrolled as here reported and as described in detail
previously [20]: (a) Healthy Donors (HD): 31 individuals tested TST and QFT-IT-negative (9
men, 22 women, median age 37 years); (b) LTBI subjects: 37 individuals (21 men,16 women,
median age 43 years) who reported household or equivalent close contacts with smear-positive
pulmonary TB patients in the previous 3 months, QFT-IT-positive, with negative chest x-Ray
results for active pulmonary lesions and no prior preventive therapy performed; (c) active TB
disease: 71 individuals diagnosed with active pulmonary TB (with a positive Mtb culture from
sputa or broncholavage, 54 men, 16 women, median range 38 years) who started specific treat-
ment<8 days before enrolment (see Table 1);(d) 34 cured TB patients (with a previous micro-
biological diagnosis, 17 women and 17 men, median age 41). Patients were recruited from the
L. Spallanzani National Institute for Infectious diseases, Rome and from the Department of
Infectious Disease, University Hospital of Palermo. All patients were treated in accordance with
Italian guidelines and received therapy for 6 months. Treatment was successful in all partici-
pants, all of whom completed the full course of anti-TB chemotherapy. None of the TB patients
had evidence of HIV infection, or was being treated with steroid or other immunosuppressive
or anti-tubercular drugs at the time of their first sampling. The study was approved by the Ethi-
cal Committee of the L. Spallanzani National Institute for Infectious diseases in Rome (approval
number 2/2007), and by the Ethical Committee of the University Hospital in Palermo (approval
number 13/2013), where the patients were recruited. Informed consent was signed by all partic-
ipants. QFT-IT was performed as for manufactures instructions.
Full differential blood counts
Full blood counts (FBC) of peripheral blood collected in ethylene-diamine tetra-acetic acid
(EDTA) containing tubes were performed by one clinical diagnostic laboratory using a five-
Monocytes during Mycobacterium tuberculosis infection
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part differential hematology analyzer(Coulter 4.500, Germany). Full blood count measurement
was under strict quality procedures including twice-daily high and low internal quality control,
fortnightly quality controls done by the clinical laboratory QC scheme and annual quality
assurance as part of clinical laboratory QC scheme. The laboratory is accredited by the Italian
National Accreditation System in accordance with international standards ISO17025/2005
and ISO 15189/2007.
Cell staining and flow cytometry analysis
Peripheral blood was drawn from patients and control donors. Surface staining was performed
on freshly drawn heparinized whole blood using mAbs toCD11c, CD16, CD32, CD64, CD70,
CD80, CD86, CD123, CD137, CD137-L, CD152, CD163, CD206, HLA-DR, RANK, RANK-L,
CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, CXCR2, CXCR3, CXCR5, CD3, CD19, CD56 and
their isotype controls, all from BD Bioscience, San Diego, USA).One hundred microliters of
blood were incubated with saturating amounts of the mAbs for 20 minutes on ice and then
were lysed with FACS Lysing Solution (BD Biosciences). Four-parameter FCM acquisition and
analysis were performed on a two-laser FACSCalibur instrument (BD Biosciences) using Cell-
Quest software (BD Biosciences). For a clear analysis, at least 50,000 total events were analyzed.
Samples were analyzed with FlowJo software (TreestarInc Ashland, OR). Monocytes were gated
first by forward angle and side scatter profiles, followed by gating on the CD14+ cell population,
and intersecting the two gated populations, for further analysis. Lymphocytes were gated first
by forward angle and side scatter profiles, followed by gating on cells expressing CD3, CD19,
CD16 and CD56. Standardization of analysis and comparability of results were related to the
use of reagents from the same producing company, instrument compensation and gating strate-
gies performed by the same operator at both time points for all subjects studied.
Table 1. Characteristics of study groups.
Healthy Donors LTBI Active TB Cured TB Total
Enrolled subjects (%) 31 (17.92%) 37 (21.39%) 71 (41.04%) 34 (19.65%) 173 (100%)
Median age 37 43 38 41 40
Range 29–60 21–77 17–82 17–73 17–82
Male gender (%) 9 (29.03%) 22 (59.46%) 54 (76.06%) 17 (50.00%) 102 (58,96%)
Origin (%)
Western Europe 31 (100%) 24 (64.86%) 16 (22.54%) 14 (41.18%) 85 (49.13%)
Eastern Europe 0 (0.00%) 4 (10.81%) 33 (46.48%) 9 (26.47%) 46 (26.59%)
Asia 0 (0.00%) 3 (8.11%) 11 (15.49%) 3 (8.82%) 17 (9.83%)
Africa 0 (0.00%) 5 (13.51%) 10 (14.08%) 4 (11.76%) 19 (10.98%)
South America 0 (0.0%) 1 (2.70%) 1 (1.41%) 3 (8.82%) 5 (2.89%)
TST (%)
Positive 0 (0.00%) 0 (0.00%) 15 (21.13%) 0 (0.00%) 15 (8.67%)
Negative 0 (0.00%) 0 (0.00%) 4 (5.63%) 0 (0.00%) 4 (2.31%)
N.D. 31 (100%) 37 (100%) 52 (73.24%) 34 (100%) 154 (89.02%)
IGRA TEST (%)
Positive 0 (0.0%) 37 (100%) 49 (58.2%) 20 106 (61.27%)
Negative 8 (25.8%) 0 (0.0%) 9 (16.5%) 2 19 (10.98%)
Indeterminate 0 (0.0%) 0 (0.0%) 2 (3.8%) 3 5 (2.89%)
N.D. 23 (74.2%) 0 (0.0%) 11 (21.5%) 9 43 (24.86%)
TB diagnosis (%)
Microbiological diagnosis 71 100% 71 (41.04%)
doi:10.1371/journal.pone.0171358.t001
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Statistical analysis
To calculate the ML ratio, the absolute monocyte count was divided by the absolute lympho-
cyte count. The median or geometric mean was used for descriptive statistics for each parame-
ter. The non-parametric Kruskal-Wallis was performed comparing the medians of ML ratio,
significance was settled for p<0.0001. The relationship between variables was evaluated using
Spearman rank correlation test. A two-side p<0.05 was considered statistically significant.
Data were analyzed using the Statistic software (Stat soft, Ohio, USA) and GraphPad prism,
version 5.0 (GraphPad Software, San Diego, CA,USA). Negative binomial regression model
was used to estimate the association between active TB and explanatory variable. To evaluate
the performance of each candidate biomarker in discriminating between patients with active
disease and LTBI subjects and establish probability cutoff values, logistic regression analysis
was performed followed by Receiver operating characteristic (ROC) curve analysis.
Results
A high ML ratio is associated with active TB disease
We assessed if ML ratio is modulated by the clinical TB condition. As shown in Table 2 and
Fig 1A, patients with active TB disease showed a higher ML ratio (Median:0.50, IQR:0.36–
0.64), compared to HD (Median: 0.18, IQR: 0.15–0.21) and LTBI subjects (Median:0.25,
IQR:0.20–0.28). Additional analysis showed that the ML ratio value decreased close to the nor-
mal range after anti-mycobacterial therapy (Median:0.25, IQR: 0.20–0.31). ML ratio of active
TB patients was significantly different compared to that of HD, LTBI subjects and cured TB
patients, in all instances with p<0.0001. Conversely, no significant differences were observed
among HD, LTBI subjects and cured TB patients.
We then evaluated whether the increased ML ratio found in patients with active TB disease
was dependent on changes in the numbers of lymphocytes, monocytes or both. As shown in
Table 2 and Fig 1B, the higher ML ratio found in patients with active TB disease was consistent
with the associated significantly higher absolute monocyte counts (Median: 0.80, IQR:0.60–
1.00) but slightly (and not significant) lower absolute lymphocyte counts (Median: 1.65, IQR:
1.30–2.03), compared to HD, and cured TB patients reaching the statistical significance when
compared with LTBI subjects with a p<0.0001 (Fig 1C). There was a significant correlation
between the ML ratio and absolute monocyte (R2: 0.4, r: 0.6, p<0.0001) and lymphocyte (R2:
0.6, r: -0.75, p<0.0001) counts, indicating that both the monocyte and lymphocyte counts con-
tribute to the altered ML ratio (Fig 2A and 2B). Moreover, we analysed whether the predictive
value of ML ratio was due to the frequency of monocytes count. Therefore we used the mono-
cyte count for the negative binomial regression modeling considering the data from active TB
patients included in the study. Monocyte count confirmed a slight association with active TB
disease (Monocyte count IRR = 1.005 95% CI 1.0046, 1.0053, with a significance >99%). To fur-
ther assess the accuracy of the ML ratio to discriminate between patients with active TB disease
Table 2. M/L ratio, monocyte and lymphocyte absolute counts of the subjects enrolled.
TB status M/L ratio Monocyte absolute count
1x103/μl
Lymphocyte absolute count
1x103/μl
N˚ of subjects enrolled Median IQR Median IQR Median IQR
HD 31 0.18 0.15–0.21 0.33 0.23–0.40 1.75 1.55–2.20
LTBI 37 0.25 0.20–0.28 0.46 0.40–0.60 2.15 1.80–2.79
Active TB 71 0.50 0.36–0.64 0.8 0.60–1.00 1.65 1.30–2.03
Cured TB 34 0.25 0.20–0.31 0.5 0.33–0.60 1.9 1.50–2.18
doi:10.1371/journal.pone.0171358.t002
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Fig 1. Ratio of monocytes to lymphocytes (ML ratio) of patients with active TB disease, LTBI subjects,
cured TB patients and HD. A. Each dot represented ML ratio of a studied individuals. A horizontal bar indicates
the median of each group. Significance of differences between groups was compared using Kruskal-Wallis test.
*p<0.00001. B. Monocyte absolute count of active TB patients at diagnosis, LTBI subjects, cured TB patients
and HD. Each dot representes the value of an individual subject. Each horizontal bar represents the median of
each group. p<0.00001 were considered statistically significant. C. Lymphocyte absolute count of active TB
patients at diagnosis, LTBI subjects, cured TB patients and HD. Each dot represents the value of an individual
subject. Each horizontal bar represents the median of each group. p<0.00001 were considered statistically
significant.
doi:10.1371/journal.pone.0171358.g001
Monocytes during Mycobacterium tuberculosis infection
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and other tested groups, ROC curves and cross-over plots were performed. As shown in Fig
2C the ML ratio well distinguishes patients with active TB from HD (AUC: 0.96, p<0.0001,
cutoff: >0.28, 91.04% and 93.55%, of sensitivity and specificity, respectively), but was less
robust to differentiate active TB patients from LTBI subjects (AUC: 0.91, p<0.0001, cutoff:
> 0.30,85.07% and 85.71 of sensitivity and specificity, respectively, Fig 2D) and cured TB
patients (AUC: 0.87, p<0.0001; cutoff: >0.34, 77.61% and 77.42% of sensitivity and specific-
ity, respectively)(Fig 3).
Fig 2. Correlation between the ML ratio and absolute monocyte and lymphocyte counts. A) The
potential association between the ML ratio and absolute monocyte count, were analyzed by Spearman rank
correlation test. Data shown are the values of the individual subjects. B) The potential association between
the ML ratio and absolute lymphocyte count were analyzed by Spearman rank correlation test. Data shown
are the values of the individual subjects. C) Receiver operating characteristic (ROC) curve for the ML ratio.
The solid line shows the result for the value of ML ratio comparing active TB vs HD. D) The solid line shows
the result for the value of ML ratio comparing active TB patients with LTBI subjects.
doi:10.1371/journal.pone.0171358.g002
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Phenotype of circulating monocytes during mycobacterial infection
We evaluated if the expression of certain activation molecules on the surface of monocytes may
also represent a robust marker to distinguish between TB stages. As shown in Fig 4A, we did
not find any significant difference in the percentage of circulating monocytes expressing any of
the aforementioned surface molecules (see Materials and Methods) in different subject cohorts.
Mean Fluorescent Intensity (MFI) was then measured to quantify surface molecule expression.
As shown in Fig 4B, the intensity of expression of three surface markers CD64, CD123 and
CD152 was significantly higher in circulating monocytes from patients with active TB disease as
compared to HD, and the intensity of expression of two of these markers (CD123 and CD152)
was also significantly higher than in cured TB patients. Fig 4C shows primary cytometry histo-
grams of one representative subject in each cohort group. However, and most interestingly, the
intensity of expression of only one marker, CD64, on circulating monocytes allowed to discrim-
inate between active TB patients and LTBI subjects (AUC value = 0.81, p = 0.003; Fig 4D).
In an attempt to investigate the clinical usefulness of CD64 expression on monocytes for
discriminating active TB patients and LTBI subjects, we examined whether a metric incorpo-
rating the ML ratio to the CD64 MFI would generate an improved performance, because both
values are increased in patients with active TB disease.
Therefore, we introduced a number of indices formulated by the ML ratio, or the absolute
monocyte count, for the MFI of CD64+monocytes. We calculated these indices multiplying the
value of geometric MFI of CD64 surface marker for the monocyte to lymphocyte ratio or for the
absolute monocyte count, respectively. From here on, we referred to these indices as ML-CD64
and Monocyte-64, respectively. As shown in Fig 5A and 5B, the ML-CD64 index significantly
discriminated between patients with active TB disease and HD (AUC = 0.850, p = 0.011) and
LTBI subjects (AUC = 0,80, p = 0.003), while the Monocyte-CD64 index significantly discrimi-
nated patients with active TB disease from HD (AUC = 0.84, p = 0.007) Fig 5C, LTBI subjects
(AUC = 0.78, p = 0.006) Fig 5D and cured TB patients (AUC = 0.77, p = 0.005) Fig 6.
Overall, these data show that the CD64-based indices display good accuracy in distinguish-
ing between patients with active TB disease and HD.
Discussion
Understanding the immune responses that underlies protection from infection or progression
to disease is important to allow the development of diagnostic tools for the efficient prevention
and management of TB [7].
Fig 3. Receiver operating characteristic (ROC) curve for the ML ratio index. The solid line shows the
result for the ML ratio value comparing patients with active TB disease to cured TB patients.
doi:10.1371/journal.pone.0171358.g003
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Monocytes play a pivotal role as cellular component of the innate immune response and
represent a link to the activation and modulation of the adaptive immune response due to
their role as antigen presenting cells. Therefore, all the factors that could perturb the functions
of monocytes, may potentially affect an individual response in the course of infections or auto-
immune diseases or tumors.
Because CD4 T cells and monocytes/macrophages were previously shown to be major effec-
tor cells in protecting the host against Mtb infection [21], we investigated whether there were
any differences in the monocyte compartment between patients with active TB disease and
Fig 4. Surface molecules expression on circulating monocytes of patients with active TB disease,
LTBI subjects, cured TB patients and HD. A) Cumulative data of the percentage expressed as median of
surface expression and IQR. B) Geometric mean fluorescence intensity (geo-mean) of different surface
molecules on monocytes and S.E. C) Representative FACS analysis of surface markers expression on
circulating monocytes of one representative subject from each cohort group. D) Receiver operating
characteristic (ROC) curve for the MFI value of CD64. The solid line shows the result for the value of
comparing active TB vs LTBI.
doi:10.1371/journal.pone.0171358.g004
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LTBI subjects, measuring their absolute number and phenotype and the consequent effect of
their number on the M/L ratio.
In the present study we showed that patients with active TB disease had a very high ML
ratio, as compared to both HD and LTBI subjects, as well as cured TB patients, suggesting that
the ML ratio is changed after anti-TB therapy and could be used a tool to evaluate treatment
success. In active TB patients, the ML ratio was significantly correlated with increased mono-
cyte counts and lower lymphocyte counts, indicating that both the monocyte count and the
lymphocyte count contribute to the altered ML ratio. Moreover, ROC curves and cross-over
plots showed that the ML ratio could contribute to distinguish patients with active TB from
HD, but was of poor value to differentiate active TB patients from LTBI subjects and cured TB
patients.
Fig 5. Receiver operating characteristic (ROC) curves for the ML-CD64 index and the Monocyte-CD64 index. A) The solid line shows the
result for the ML-CD64 index value comparing patients with active TB disease to HD. B) The solid line shows the result for the ML-CD64 index value
comparing patients with active TB disease to LTBI subjects. C) The solid line shows the result for the monocyte-CD64 index value comparing
patients with active TB disease to HD. D) The solid line shows the result for themonocyte-CD64 index value comparing patients with active TB
disease to LTBI subjects.
doi:10.1371/journal.pone.0171358.g005
Monocytes during Mycobacterium tuberculosis infection
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ML ratio has been investigated in different context of infectious and non-infectious dis-
eases. Recent studies have demonstrated that hematopoiesis may be perturbed by mycobacte-
rial infection [22] or the pathogen may infect bone marrow mesenchymal stem cells [23]. In
humans and in mice [24, 25], it has been demonstrated that subsets of hematopoietic stem
cells have distinct biases in the ratio of myeloid and lymphoid cells they give rise to [26, 27].
Fletcher et al., have examined gene expression in 10-week-old BCG-vaccinated HIV-unin-
fected infants using whole-transcriptome micro arrays and have suggested that activation/qui-
escence of hematopoietic stem cell compartment was more prevalent among infants who
developed TB respect to the infants that did not developed the disease [16]. From these data,
the authors conclude that the transcriptomic may reflect leucocyte subset frequencies, suggest-
ing that the quantity of myeloid and lymphoid transcripts in peripheral blood could be consid-
ered as a marker of the frequency of leucocyte subsets.
Naranbhai et al, reported that the ratio of ML in HIV-infected South African adults prior to
combination antiretroviral therapy initiation (cART), was predictive of TB disease during the
subsequent five years on cART [17]. Finally, and very recently, the same authors have demon-
strated that increase of the ML ratio is associated with change of gene transcription in mono-
cytes that may be correlated with their impaired anti-mycobacterial profiles, speculating on
the association of this finding with pathophysiologic conditions [28]. Additionally, alteration
in monocyte functions may alter crosstalk with lymphocytes and adaptive immune responses
[29, 21], hence changes in monocyte functions alone may have a role in the detrimental
immune response.
We have also investigated on the expression of circulating monocytes surface markers to
identify whether a particular phenotype could be associated with the state of Mtb infection/dis-
ease. In fact, M1 macrophages are usually correlated with the resistance against intracellular
pathogens such as L. monocytogenes and S. typhimurium [30, 31], as well as with the early
phases of infection with bacteria such as M. tuberculosis [32, 24], M. ulcerans, and M. avium
Fig 6. Receiver operating characteristic (ROC) curve for the monocyte-CD64 index. The solid line
shows the result for the monocyte-CD64 value comparing patients with active TB disease to cured TB
patients.
doi:10.1371/journal.pone.0171358.g006
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PLOS ONE | DOI:10.1371/journal.pone.0171358 February 16, 2017 10 / 14
[33,34]. The excessive inflammation due to the uncontrolled M1 proliferation and activation is
associated with acute bacterial infections and sepsis [35]. The switch of macrophages from M1
to M2 observed during the transition from acute to chronic infection, may provide protection
against overwhelming uncontrolled inflammation; however, this switch could favor pathogens
that have the ability to evade the immune response of the host interfering with M1-associated
killing [33, 36–39].
Recently a modulation of M1-related, but not of M2-related genes evaluated by transcrip-
tional profiles of patients with active TB has been shown. Similar results were obtained in
infants vaccinated with bacillus Calmette–Guerin [40–42].
In the present study, we didn’t find any clear M1 or M2 polarization of circulating monocytes.
Differently, we found that CD64, CD123 and CD152 were over expressed in patients with active
TB disease respect to HD group. Moreover, expression of CD64, measured as MFI, allowed the
discrimination between active TB patients and LTBI subjects. Additionally, CD64-expressing
monocyte-based indices gave better performance in discrimination between patients with active
TB disease and LTBI subjects.
The meaning of the over expression of these molecules could be partially explained with
their role played during the different TB stages. CD64is able to induce phagocytosis, respira-
tory burst and antibody-dependent cell-mediated cytotoxicity in granulocytes [43]. CD64 pro-
tein expression is increased in monocytes from TB patients and as well as the CD64 expression
at the RNA and cell surface protein level [43]. CD64 is induced by type-I and type-IIIFN [43,
44], suggesting that the modulation of expression of certain surface markers on human mono-
cytes might reflect differential cytokine production and mark different stages of Mtb infection/
disease.
In conclusion, in this pilot study we found a correlation between the absolute number and
phenotype of monocytes and the different TB stages. The comprehension of the mechanisms
involved in the change of this cellular population should be confirmed in a larger cohort of
patients.
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